Skip to main content

Advertisement

Table 2 List of the 35 miRNAs used to classify patients into SVR and non-SVR groups using Monte Carlo Cross Validation (MCCV)

From: Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C

Gene name fold change (SVR/non SVR) T-test   Selection by MCCV
    Rank appearance frequency in this classification (%) appearance number of times
hsa-miR-122a 1.32 6.67E-02 1 98.78 889
hsa-miR-21 1.19 3.62E-01 2 94.67 852
hsa-miR-22 1.23 7.80E-02 3 93.22 839
hsa-let-7a 1.14 3.57E-01 4 92.33 831
hsa-miR-23b 1.41 1.72E-02 5 91.44 823
hsa-miR-26a 1.32 7.45E-02 6 90.78 817
hsa-let-7f 1.15 4.04E-01 7 88.67 798
hsa-miR-142-3p 1.39 1.45E-01 8 87.33 786
hsa-miR-494 2.18 5.85E-03 9 82.00 738
hsa-miR-194 1.22 1.70E-01 10 80.78 727
hsa-let-7b 1.11 3.59E-01 11 80.22 722
hsa-miR-148a 1.25 2.28E-01 12 79.67 717
hsa-miR-29a 1.16 2.73E-01 13 77.78 700
hsa-miR-125b 1.20 2.37E-01 14 73.11 658
hsa-miR-192 1.09 4.89E-01 15 69.67 627
hsa-miR-24 1.25 8.31E-02 16 68.89 620
hsa-miR-768-3p 1.19 1.78E-01 17 68.78 619
hsa-miR-126 1.07 6.75E-01 18 49.56 446
hsa-miR-19b 1.15 2.98E-01 19 48.89 440
hsa-miR-370 2.00 1.44E-02 20 39.00 351
hsa-miR-29c 1.26 1.37E-01 21 38.89 350
hsa-miR-16 1.24 2.08E-01 22 37.11 334
hsa-miR-145 1.01 9.25E-01 23 34.89 314
hsa-let-7c 1.21 1.41E-01 24 33.22 299
hsa-miR-215 1.20 3.65E-01 25 27.67 249
hsa-let-7g 1.16 3.64E-01 26 27.44 247
hsa-miR-451 1.13 6.94E-01 27 23.11 208
hsa-miR-26b 1.30 2.26E-01 28 22.22 200
hsa-miR-92 1.12 3.44E-01 29 21.11 190
hsa-miR-29b 1.19 2.62E-01 30 19.44 175
hsa-miR-107 1.21 1.58E-01 31 18.78 169
hsa-miR-27b 1.40 2.32E-02 32 18.11 163
hsa-miR-638 1.32 5.57E-02 33 16.89 152
hsa-miR-199a* 1.12 5.92E-01 34 16.78 151
hsa-miR-193b 1.25 7.24E-02 35 16.67 150